Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Benzoyl peroxide. preparations of 5% or less as a single ingredient U MAY / 08
Benztropine or its saltsPDL

including but not limited to benzatropine

I DEC / 13
Benzydamine or its saltsPDL I DEC / 13
Benzyl benzoate II SEP / 98
Bepotastine or its salts or derivativesPDL I NOV / 16
BeractantPDL I DEC / 13
Besifloxacin or its saltsPDL I DEC / 13
Betahistine or its saltsPDL I DEC / 13
Betaine or its saltsPDL

for human use, when sold or recommended for the treatment of homocystinuria

I DEC / 13
Betaine or its salts.PDL

for veterinary use

I DEC / 13
Betaxolol or its saltsPDL I DEC / 13
Bethanechol chloridePDL I DEC / 13
Bethanidine or its saltsPDL I DEC / 13
BevacizumabPDL I DEC / 13
Bezafibrate or its salts or derivativesPDL I DEC / 13
BicalutamidePDL I DEC / 13
Bictegravir or its saltsPDL I AUG / 18
Bilastine or its salts or derivativesPDL I AUG / 16
Binimetinib or its saltsPDL I MAY / 21
Biperiden or its saltsPDL I DEC / 13
Bisacodyl

when sold in strengths of 10mg or less per rectal dosage unit/suppository, in package sizes containing no more than 50mg of bisacodyl

U JUL / 21
Bisacodyl

when sold in strengths of 5mg or less per oral dosage unit, in package sizes containing no more than 105 mg of bisacodyl

U JUL / 21
Bisacodyl and its salts

(except when sold in strengths of 5mg or less per oral dosage unit in package sizes containing no more than 105mg of bisacodyl and except when sold in strengths of 10mg or less per rectal dosage unit/suppository in package sizes containing no more than 50mg of bisacodyl)

III JUL / 21
Bishydroxycoumarin or its salts or derivativesPDL I DEC / 13
Bisoprolol or its saltsPDL I DEC / 13
Bitolterol or its saltsPDL I DEC / 13
BivalirudinPDL I DEC / 13
BleomycinPDL I DEC / 13
BlinatumomabPDL I AUG / 16
Boceprevir or its derivativesPDL I DEC / 13
Boric acid and its salts in preparations for systemic use, or ophthalmic preparations in concentrations over 2%[Note: does not apply to contact lens solutions intended to be rinsed off prior to insertion in the eye] II DEC / 98
BortezomibPDL I DEC / 13
Bosentan or its salts or derivativesPDL I DEC / 13
Bosutinib or its saltsPDL

including but not limited to Bosutinib methanoate

I AUG / 14
Botulinum toxinPDL

including but not limited to onabotulinumtoxin A, incobotulinumtoxin A, abobotulinumtoxin A, rimabotulinumtoxin B, prabotulinumtoxin A

I DEC / 13
Brentuximab vedotinPDL I DEC / 13
Bretylium tosylatePDL I DEC / 13
Brexpiprazole or its saltsPDL I APR / 17
Brexucabtagene autoleucelPDL I JUL / 21
Brigatinib or its saltsPDL I AUG / 18
Brilliant Blue G or its derivativesPDL I MAY / 21
Brimonidine or its saltsPDL I DEC / 13
Brivaracetam or its derivativesPDL I AUG / 16
BrodalumabPDL I MAY / 18
BrolucizumabPDL I JUL / 20
BromalPDL I DEC / 13
Bromal hydratePDL I DEC / 13
BrometonePDL I DEC / 13
Bromfenac or its saltsPDL I MAY / 15
BromisovalPDL I DEC / 13
Bromocriptine or its saltsPDL I DEC / 13
BromoformPDL I DEC / 13
Brompheniramine and its salts as a single entity for the treatment of allergies III JAN / 03
Brompheniramine and its salts. in combination products for the relief of cough and cold symptoms U JAN / 03
Buclizine II SEP / 98
Bufexamac II SEP / 98
Bumetanide or its salts or derivativesPDL I DEC / 13
Bupivacaine and its salts for topical use on mucous membranes except lozenges III SEP / 98
Bupivacaine and its salts for parenteral or ophthalmic use II SEP / 98
Bupropion or its saltsPDL I DEC / 13
BurosumabPDL I DEC / 18
Buserelin or its saltsPDL I DEC / 13
Buspirone or its saltsPDL I DEC / 13
BusulfanPDL I DEC / 13
Butacaine and its salts for ophthalmic or parenteral use II SEP / 98
Butaperazine or its saltsPDL I DEC / 13
Butenafine 1% cream U SEP / 99
Butoconazole or its saltsPDL I DEC / 13
Butorphanol and its salts C I JUN / 02
Butyl chloral hydratePDL I DEC / 13
Cabergoline or its saltsPDL I DEC / 13
Cabotegravir or its saltsPDL I JUL / 20
Cabozantinib or its saltsPDL I NOV / 18
CalcifediolPDL I JUL / 18
CalcipotriolPDL I DEC / 13
CalcitoninPDL I DEC / 13
CalcitriolPDL I DEC / 13
Calcium bromidePDL I DEC / 13
Calcium bromolactobionatePDL I DEC / 13
Calcium carbimidePDL I DEC / 13
Calcium chloride in injectable form for parenteral nutrition I JAN / 03
Calcium disodium edetate II SEP / 98
Calcium gluconate in injectable form for parenteral nutrition I JAN / 03
Calcium polycarbophil III SEP / 98
Calcium salts when sold for the treatment of hyperphosphatemiaPDL I DEC / 13
Camphor in oleaginous vehicles and in liquid forms in concentrations greater than 11% II OCT / 98
CanagliflozinPDL I JUL / 14
CanakinumabPDL I DEC / 13
Candesartan or its salts or derivativesPDL

including but not limited to candesartan cilexetil

I DEC / 13
Candicidin or its salts or derivativesPDL I DEC / 13
Cantharides, their preparations and derivatives II SEP / 98
CaplacizumabPDL I JUL / 20
Capreomycin or its salts or derivativesPDL I DEC / 13
Captodiamine or its saltsPDL I DEC / 13
Captopril or its saltsPDL I DEC / 13
CarbacholPDL I DEC / 13
CarbamazepinePDL I DEC / 13
Carbapenem salts or derivativesPDL

Including but not limited to: Doripenem, ertapenem, imipenem, meropenem

I DEC / 18
Carbenoxolone or its saltsPDL I DEC / 13
Carbetocin or its saltsPDL I DEC / 13

1856 result(s)


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act